-+ 0.00%
-+ 0.00%
-+ 0.00%

Werewolf Therapeutics Q1 EPS $(0.40) Beats $(0.44) Estimate

Benzinga·05/08/2025 11:11:11
Listen to the news
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.44) by 9.09 percent. This is a 2.56 percent decrease over losses of $(0.39) per share from the same period last year.